Nov. 4, 2024 — Volpara Health has announced a new contract with the U.S. Defense Health Agency (DHA) valued at $7.3 million over five years. The contract will see Volpara's Patient Hub, an advanced mammography reporting, cancer risk assessment and patient tracking system, deployed across DHA's military health system. The goal is to modernize breast cancer screening and patient management for military personnel and their families.
The DHA is part of the U.S. Department of Defense and is responsible for healthcare services for approximately 9.6 million active-duty military members, retirees and their families across the Army, Navy, Air Force, and Marines.
Volpara's Patient Hub integrates critical aspects of breast health management, including scheduling data collection, risk assessment and mammogram tracking. These features ensure that healthcare providers can deliver personalized, timely care through automated follow-ups, reminders, and patient communications. Patient Hub reduces administrative burdens, streamlines workflow and facilitates adherence to breast health guidelines—all vital to improving early detection and breast cancer outcomes.
"Working with the Defense Health Agency is a tremendous opportunity to improve healthcare for those who serve our nation," said Teri Thomas, CEO of Volpara and CBO of Lunit. "Achieving certification to meet the Department of Defense's rigorous security standards demonstrates our commitment to patient care and data security. We look forward to providing state-of-the-art solutions that make a difference in breast health outcomes."
Previous generations of the company's mammography reporting software have been in use by the Department of Defense since 1990.
For more information, visit www.volparahealth.com.
October 03, 2022 
